medigraphic.com
ISSN 0028-3851 (Print)

2018, Number 2

<< Back Next >>

Rev Neurol Neurocir Psiquiat 2018; 46 (2)

Neurological disorders associated with obstructive sleep apnea syndrome

Alegría LMA, Galnares-Olalde JA

Language: Spanish
References: 29
Page: 44-47
PDF size: 201.30 Kb.


ABSTRACT

Obstructive sleep apnea syndrome (OSAS) is a sleep disorder characterized by intermittent (either partial or complete) collapse of the airway resulting in frequent episodes of apnea and hypo-apnea. This disorder has been associated with different neurological pathologies, being the cerebral vascular event, epilepsy, Parkinson and central nervous system tumors, the most frequent.


REFERENCES

  1. Kapur VK. Obstructive sleep apnea: diagnosis, epidemiology, and economics. Respir Care. 2010; 55 (9): 1155-1167.

  2. Young T, Skatrud J, Peppard P. Risk factors for obstructive sleep apnea in adults. JAMA. 2004; 291 (16): 2013-2016.

  3. Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017; 13 (3): 479-504.

  4. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013; 177 (9): 1006-1014.

  5. Franklin KA, Lindberg E. Obstructive sleep apnea is a common disorder in the population—a review on the epidemiology of sleep apnea. J Thorac Dis. 2015; 7 (8): 1311-1322.

  6. Jackson ML, Howard ME, Barnes M. Cognition and daytime functioning in sleep-related breathing disorders. Prog Brain Res. 2011; 190: 53-68.

  7. Netzer N, Werner P, Jochums I, Lehmann M, Strohl KP. Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke. 1998; 29 (1): 87-93.

  8. Beaudin AE, Pun M, Yang C, Nicholl DD, Steinback CD, Slater DM et al. Cyclooxygenases 1 and 2 differentially regulate blood pressure and cerebrovascular responses to acute and chronic intermittent hypoxia: implications for sleep apnea. J Am Heart Assoc. 2014; 3 (3): e000875.

  9. Wallace DM, Ramos AR, Rundek T. Sleep disorders and stroke. Int J Stroke. 2012; 7: 231-242.

  10. Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med. 2010; 6 (2): 131-137.

  11. Birbkak J, Clark A, Hulvej N. The effect of sleep disordered breathing on the outcome of stroke and transient ischemic attack: a systematic review. J Clin Sleep Med. 2014; 10 (1): 103-113.

  12. Yaranov DM, Smyrlis A, Usatii N, Butler A, Petrini JR, Mendez J et al. Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation. Am J Cardiol. 2015; 115 (4): 461-465.

  13. Turkington PM, Allgar V, Bamford J, Wanklyn P, Elliott MW. Effect of upper airway obstruction in acute stroke on functional outcome at 6 months. Thorax. 2004; 59: 367-371.

  14. Parra OA. Sleep-related breathing disorders: Impact on mortality of cerebrovascular disease. Eur Respir J. 2004; 24: 267-272.

  15. Portela PC, Fumadó JC, García HQ, Borrego FR. Sleep-disordered breathing and acute stroke. Cerebrovasc Dis. 2009; 27 Suppl 1: 104-110.

  16. Minnerup J, Ritter MA, Wersching H, Kemmling A, Okegwo A, Schmidt A et al. Continuous positive airway pressure ventilation for acute ischemic stroke: a randomized feasibility study. Stroke. 2012; 43 (4): 1137-1139.

  17. Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012; 307 (20): 2161-2168.

  18. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X et al. N Engl J Med. CPAP for prevention of cardiovascular events in obstructive sleep apnea. 2016; 375 (10): 919-931.

  19. Chen JC, Tsai TY, Li CY, Hwang JH. Obstructive sleep apnea and risk of Parkinson’s disease: a population-based cohort study. J Sleep Res. 2015; 24 (4): 432-437.

  20. Rothman S, Mattson M. Sleep disturbances in Alzheimer’s and Parkinson’s diseases. Neuromolecular Med. 2012; 14: 194-204.

  21. Hsiao YH, Chen YT, Tseng CM, Wu LA, Perng DW, Chen YM et al. Sleep disorders and an increased risk of Parkinson’s disease in individuals with non-apnea sleep disorders: a population-based cohort study. J Sleep Res. 2017; 26 (5): 623-628.

  22. Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B et al. Prodromal features for Parkinson’s disease—baseline data from the TREND study. Eur J Neurol. 2014; 21 (5): 766-772.

  23. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology. 2004; 62: S24-S29.

  24. Devinsky O, Ehrenberg B, Barthlen GM, Abramson HS, Luciano D. Epilepsy and sleep apnea syndrome. Neurology. 1994; 44 (11): 2060-2064.

  25. Chihorek AM, Abou-Khalil B, Malow BA. Obstructive sleep apnea is associated with seizure occurrence in older adults with epilepsy. Neurology. 2007; 69 (19): 1823-1827.

  26. Rains JC, Poceta JS, Penzien DB. Sleep and headaches. Curr Neurol Neurosci Rep. 2008; 8: 167-175.

  27. Kristiansen HA, Kværner KJ, Akre H, Overland B, Russell MB. Tension-type headache and sleep apnea in the general population. J Headache Pain. 2011; 12 (1): 63-69.

  28. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 2008; 15: 678-685.

  29. Chen JC, Hwang JH. Sleep apnea increased incidence of primary central nervous system cancers: a nationwide cohort study. Sleep Med. 2014; 15 (7): 749-754.




2020     |     www.medigraphic.com